SURVYR

CLPT

ClearPoint Neuro, Inc.
$9.25
+$0.00 (0.00%)Oct 22 close
Healthcare CompareTechnicals
1M3M6M1Y2Y
-67%-46%-25%-4%+17%Oct 2025Oct 2026Apr 202652w high $27.2752w low $8.27
CLPTSPY
Wall St. Highest PT $25.00 (+170.3%) Wall St. Avg PT $23.50 (+154.1%)
$9$15$21$27$34POC $15Hi $25Avg $24
Underwater Drawdown %Max DD -67.9%Current -65.7%
0.0%-67.9%
Relative Strength vs SPY-78.0% vs SPYUnderperforming
+91%0%-91%
1W
−$0.39 (4.05%)
1M
−$6.54 (41.42%)
3M
−$5.24 (36.16%)
6M
−$1.50 (13.95%)
YTD
−$4.43 (32.38%)
1Y
−$15.04 (61.92%)

Chart

Loading live chart…

Ratings & dials

1m · 5m · 15m · 1h · 4h · 1D

Analyst & Morningstar ratings

Consensus · Targets · Morningstar
Analyst price targets
Current price$9.25
Average target$23.50
+$14.25 (+154.1%) upsideaverage target vs current price
CurrentAverageMedian
Low$22.00
Median$23.50
High$25.00
12-month Wall Street target range
Recent analyst rating changes · 13
Reiterated
2026-06-18 · B. Riley Securities reiterated Buy on CLPT
Reiterated
2026-03-18 · B. Riley Securities reiterated Buy on CLPT
Reiterated
2026-03-05 · B. Riley Securities reiterated Buy on CLPT
Reiterated
2025-04-25 · B. Riley Securities reiterated Buy on CLPT
Reiterated
2025-04-01 · Stifel reiterated Buy on CLPT
Reiterated
2025-01-28 · B. Riley Securities reiterated Buy on CLPT
All analyst rating changes ›

Third-party ratings, not SURVYR.'s views.

Key stats & company

Market value$278.8M
P/E (next 12 months, estimated)-7.6
52-week range$8.27 – $27.27
Revenue growth (latest quarter vs a year ago)+18.1%
Dividend yieldNo dividend
Average analyst price target$23.50 (+154%)

What they do

ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States. The company offers ClearPoint systems, such as ClearPoint hardware, which includes head fixation frame, computer workstation, and in-room monitor.

Healthcare · Medical Devices
Valuation and fundamentals

Valuation & fundamentals

Loading the valuation from SEC filings…

For information only · Important disclosures

Grades vs sector

No sector grades for CLPT yet. Grades rank S&P 1500 stocks within their sector and refresh after each daily data run, so a stock outside that index or newly covered has none.

Systematic Models

Not held by any of our 7 live models right now.

Quality Growth
Outside this model's universe or screens
 Momentum Top 15
Outside this model's universe or screens
 Momentum Blend
Not in the current book
 New Highs Growth
Outside this model's universe or screens
 SURVYR. Barbell Momentum & T-Bill Shield
Outside this model's universe or screens
 SURVYR. Physical AI Grid & Power
Outside this model's universe or screens
 SURVYR. Long Book
Not in the current book

Earnings & events

CLPT earningsReports tomorrow
Next report · quarter Sep 2026
Wed Oct 28, 2026After the close
EPS consensus-$0.32 range -$0.36–-$0.27
Revenue consensus$12.3M 2 analysts
Last 4 quarters · EPS vs estimate
Aug 3, 2026-$0.38est -$0.29−32.6%Below estimates
May 13, 2026-$0.32est -$0.27−17.1%Below estimates
Mar 17, 2026-$0.27est -$0.20−35.0%Below estimates
Nov 6, 2025-$0.21est -$0.20−5.0%Below estimates

In line = within 1% of the estimate.

Source: Yahoo Finance · report time: Nasdaq earnings calendar · refreshed 2026-10-24 08:16:30 ET
24-1125-0225-0525-0825-1126-0326-0526-08-0.380.00
EstimateActual (beat)Actual (miss)

Quarterly revenue

QuarterRevenueYoY
2026-06-30$10.9M+18.1%
2026-03-31$12.1M–
2025-12-31$10.4M–
2025-09-30$8.9M–
2025-06-30$9.2M–

News & catalysts

More news
ClearPoint Neuro to Announce Third Quarter 2026 Results October 28, 2026
ACCESS Newswire · Oct 14
AngioDynamics (ANGO) Reports Q1 Loss, Lags Revenue Estimates
Zacks · Oct 08
ClearPoint Neuro Shares Fall 24% Following uniQure AMT-130 Trial Update
InvestorsHub · Sep 29
Alphatec (ATEC) Moves 19.7% Higher: Will This Strength Last?
Zacks · Sep 14
ClearPoint Neuro (CLPT) Stock Sees Fair Value Cut As Analysts Factor In Heavier Investment
Simply Wall St. · Sep 04
Rating changes
Reiterated
2026-06-18 · B. Riley Securities reiterated Buy on CLPT
Reiterated
2026-03-18 · B. Riley Securities reiterated Buy on CLPT
Reiterated
2026-03-05 · B. Riley Securities reiterated Buy on CLPT
Reiterated
2025-04-25 · B. Riley Securities reiterated Buy on CLPT
Reiterated
2025-04-01 · Stifel reiterated Buy on CLPT
Reiterated
2025-01-28 · B. Riley Securities reiterated Buy on CLPT

Third-party analyst actions, not SURVYR.'s views. All rating changes

Stats refreshed 2026-10-24 08:16:30 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now

Morning Brief (8 AM ET) & Market Close (4:30 PM ET), weekdays

Indexes, sectors, biggest movers, rates, top news, SURVYR. model changes and what's ahead. Free, two short emails each weekday.

Editions

Free. Not investment advice. Unsubscribe anytime.

SURVYR

Free to use. No card, no ads, no auto-renew.

Systematic research · Not investment advice · Hypothetical unless marked Live · Data: Yahoo Finance (15-min delayed), SEC EDGAR, House Clerk · Important disclosures · Contact desk@coteau.app

How it worksOur promiseTermsPrivacyData statusSend feedback
Coteau 0.9 · Oct 21, 2026